Security Snapshot

Rallybio Corp - COMMON STOCK (RLYB) Institutional Ownership

CUSIP: 75120L209

13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

38

Shares (Excl. Options)

4,666,407

Price

$8.97

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COMMON STOCK
Symbol
RLYB on Nasdaq
Shares outstanding
5,299,981
Price per share
$8.80
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
4,666,407
Total reported value
$41,853,824
% of total 13F portfolios
0%
Share change
+4,529,258
Value change
+$40,706,436
Number of holders
38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • RLYB - Rallybio Corp - COMMON STOCK is tracked under CUSIP 75120L209.
  • 38 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 38 between Q4 2025 and Q1 2026.
  • Reported value moved from $6,861 to $41,853,824.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 38 institutions filings for Q1 2026.

Open SEC Evidence

Security key

75120L209

Latest holder period

Q1 2026

13F holders

38

13D/G owners

2

CIK / CUSIP context first

Significant Owners of Rallybio Corp - COMMON STOCK (RLYB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 11% +50% $2,679,776 +$901,392 561,798 +51% FMR LLC 04 Mar 2026
5AM Ventures V, L.P. 5.5% 291,788 Andrew J. Schwab 25 Feb 2026

As of 31 Mar 2026, 38 institutional investors reported holding 4,666,407 shares of Rallybio Corp - COMMON STOCK (RLYB). This represents 88% of the company’s total 5,299,981 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Rallybio Corp - COMMON STOCK (RLYB) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 793,451 0% $7,117,256
VIKING GLOBAL INVESTORS LP 9.9% 524,347 0.01% $4,703,393
Cormorant Asset Management, LP 7.5% 400,000 0.18% $3,588,000
TPG GP A, LLC 7.1% 378,551 0.09% $3,395,602
Balyasny Asset Management L.P. 7.1% 376,573 0.01% $3,377,860
Laurion Capital Management LP 5.7% 302,756 0.25% $2,715,721
Nantahala Capital Management, LLC 5.7% 300,635 0.17% $2,696,696
Pivotal bioVenture Partners Investment Advisor LLC 5.7% 300,579 0.96% $2,696,194
5AM Venture Management, LLC 5.5% 291,788 0.73% $2,617,338
Almitas Capital LLC 3.6% 191,206 0.39% $1,715,118
RENAISSANCE TECHNOLOGIES LLC 3% 156,527 0% $1,404,047
JOHNSON & JOHNSON 2.9% 152,901 0.21% $1,371,522
VANGUARD CAPITAL MANAGEMENT LLC 2.1% 112,040 0% 0% $1,004,999
AJU IB Investment Co., Ltd. 1.8% 94,334 2.8% $846,176
Mariner, LLC 0.95% 50,566 0% $453,577
GEODE CAPITAL MANAGEMENT, LLC 0.67% 35,425 0% $317,821
DELTEC ASSET MANAGEMENT LLC 0.64% 33,750 0.06% $302,737
Rangeley Capital, LLC 0.57% 30,130 0.29% $270,266
GTS SECURITIES LLC 0.42% 22,016 0.01% $197,484
ADAR1 Capital Management, LLC 0.39% 20,535 0.01% $184,199
CITADEL ADVISORS LLC 0.38% 19,886 0% $178,377
BlackRock, Inc. 0.33% 17,486 0% $156,849
VANGUARD FIDUCIARY TRUST CO 0.26% 13,547 0% 0% $121,517
DIMENSIONAL FUND ADVISORS LP 0.21% 11,280 0% $101,182
XTX Topco Ltd 0.21% 11,226 0% $100,697

Institutional Holders of Rallybio Corp - COMMON STOCK (RLYB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,666,407 $41,853,824 +$40,706,436 $8.97 38
2025 Q4 10,000 $6,861 +$6,861 $0.69 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .